4-Iodo-1-isobutyl-1H-pyrazole – (918487-09-9)

carvedilol, 72956-09-3, Coreg, Dilatrend, Eucardic, Carvedilolum, Kredex, Carvedilolum [Latin], 1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol, Dimitone, Artist, Querto, BM 14190, BM-14190, SKF 105517, Coronis, Korvasan, Talliton, DQ 2466, 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol, DQ-2466, HSDB 7044, (+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol, NSC-758694, UNII-0K47UL67F2, SK&F-105517, CHEBI:3441, BM 14.190, BM-14-190, BM-14.190, C07AG02, 0K47UL67F2, MFCD00864692, CHEMBL723, SKF-105517, [3-(9H-carbazol-4-yloxy)-2-hydroxypropyl][2-(2-methoxyphenoxy)ethyl]amine, DTXSID8022747, Carvedilolum (Latin), NSC 758694, Carvedilol [USAN:USP:INN:BAN:JAN], 1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol, CARVEDILOL (MART.), CARVEDILOL [MART.], 2-Propanol, 1-(9H-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-, (+-)-, CARVEDILOL (USP-RS), CARVEDILOL [USP-RS], CARVEDILOL (EP MONOGRAPH), CARVEDILOL [EP MONOGRAPH], CARVEDILOL (USP MONOGRAPH), CARVEDILOL [USP MONOGRAPH], Coropress, Dibloc, 1-((9H-Carbazol-4-yl)oxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol, 1-(9H-Carbazol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol, Carvedilol (USAN:USP:INN:BAN:JAN), 1-(9H-carbazol-4-yloxy)-3-[(2-{[2-(methyloxy)phenyl]oxy}ethyl)amino]propan-2-ol, SMR000449280, Artist (TN), Coreg (TN), SR-01000759289, carvedilolo, MFCD00869663, 1-(9H-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol, 1-(9H-Carbozol-4-yloxy)-3-[[2-(2-methoxy phenoxy)ethyl]amino]-2-propanol, EG-P042, (R)-BM 14190, Carvedilol-methyl-d3, BM14190, Carvedilol (Standard), Spectrum_001665, CARVEDILOL [MI], CARVEDILOL [INN], CARVEDILOL [JAN], Spectrum2_001673, Spectrum3_001182, Spectrum4_000636, Spectrum5_001436, CARVEDILOL [HSDB], CARVEDILOL [USAN], CARVEDILOL [VANDF], CARVEDILOL [WHO-DD], SCHEMBL22293, GTPL551, KBioGR_001252, KBioSS_002145, MLS000758299, MLS000759508, MLS001424092, MLS006011886, SPBio_001885, Carvedilol (JP17/USP/INN), Carvedilol – Bio-X trade mark, DTXCID602747, CARVEDILOL [ORANGE BOOK], SCHEMBL10082334, SCHEMBL13287211, BDBM25759, HY-B0006R, KBio2_002145, KBio2_004713, KBio2_007281, KBio3_002323, GLXC-03245, HMS2051N03, HMS2089B09, HMS2093E12, HMS3261E15, HMS3269N11, HMS3393N03, HMS3413B14, HMS3655O14, HMS3677B14, HMS3715D15, HMS3750I15, HMS3884E12, Pharmakon1600-01504257, Carvedilol 1.0 mg/ml in Methanol, BCP23386, EX-A5746, HY-B0006, Tox21_500347, BBL029064, MFCD00869664, NSC758694, s1831, STK621453, AKOS005554967, Carvedilol, >=98% (HPLC), solid, AC-1641, BCP9000493, CCG-100917, CCG-207952, CS-1194, DB01136, FC11729, KS-1037, LP00347, NC00167, SB17441, SDCCGSBI-0206771.P002, NCGC00167832-01, NCGC00167832-02, NCGC00167832-03, NCGC00167832-04, NCGC00167832-19, NCGC00261032-01, BC164291, SY129821, SY283162, BCP0726000253, SBI-0206771.P001, DB-055704, DB-057556, DB-057557, C2260, NS00002339, SW197547-3, C06875, D00255, F19969, AB00639903-07, AB00639903-09, AB00639903_10, AB00639903_11, AB00639903_12, L001243, Q412534, SR-01000759289-5, SR-01000759289-6, SR-01000759289-9, BRD-A10977446-001-04-8, BRD-A10977446-001-05-5, BRD-A10977446-001-12-1, BRD-A10977446-001-13-9, BRD-A10977446-001-14-7, BRD-A10977446-011-01-3, BRD-A10977446-045-01-1, Z1515383337, Carvedilol, European Pharmacopoeia (EP) Reference Standard, Carvedilol, United States Pharmacopeia (USP) Reference Standard, 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxy-phenoxy)-ethylamino]-propan-2-ol, Carvedilol, Pharmaceutical Secondary Standard Certified Reference Material, (+/-)-1-CARBAZOL-4-YLOXY)-3-((2-(O-METHOXYPHENOXY)ETHYL)AMINO)-2-PROPANOL, (2RS)-1-(9H-Carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol, 1-(CARBAZOL-4-YLOXY)-3-((2-(O-METHOXY-PHENOXY)ETHYL)AMINO)-2-PROPANOL, Carvedilol for system suitability, European Pharmacopoeia (EP) Reference Standard, 107741-96-8, 2-PROPANOL, 1-(9H-CARBAZOL-4-YLOXY)-3-((2-(2-METHOXYPHENOXY)ETHYL)AMINO)-, (+/-)-